These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 44122)

  • 21. Psychiatric complications of medical drugs.
    Flaherty JA
    J Fam Pract; 1979 Aug; 9(2):243-51. PubMed ID: 379269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Levodopa-induced psychosis in patients with idiopathic Parkinson disease].
    García-Escrig M; Bermejo Pareja F; Fernández Ponsatí JT
    Med Clin (Barc); 1999 Feb; 112(7):245-50. PubMed ID: 10220750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The problem of side effects after a treatment with L-dopa in the Parkinson's syndrome: clinical and animal studies (author's transl)].
    Sommer H; Fischer GJ; Quandt J
    Folia Clin Int (Barc); 1974 Oct; 24(10):681-95. PubMed ID: 4279185
    [No Abstract]   [Full Text] [Related]  

  • 24. [Unwanted effects of psychotropic drugs--selected results from a 10-year multicenter project monitoring drugs in psychiatry].
    Grohmann R; Schmidt LG; Antretter K; Rüther E
    Internist (Berl); 1990 Jul; 31(7):468-74. PubMed ID: 1975570
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
    Yamada K; Goto S; Hamasaki T; Kuratsu JI
    Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The two faces of L-DOPA: benefits and adverse side effects in the treatment of Encephalitis lethargica, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis.
    Foster HD; Hoffer A
    Med Hypotheses; 2004; 62(2):177-81. PubMed ID: 14962622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Various encephalopathies caused by drugs].
    Uldry PA; Regli F; Naegeli C
    Schweiz Rundsch Med Prax; 1989 Jun; 78(23):658-62. PubMed ID: 2568672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Psychological changes in Parkinson disease].
    Danielczyk W
    Wien Med Wochenschr; 1986 Aug; 136(15-16):396-9. PubMed ID: 3788191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing.
    Schindehütte J; Trenkwalder C
    Clin Neurol Neurosurg; 2007 Feb; 109(2):188-91. PubMed ID: 16949733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Toxic and adverse neurological effects of anti-parkinsonian drugs].
    Sunohara N
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):527-31. PubMed ID: 10434715
    [No Abstract]   [Full Text] [Related]  

  • 31. [Ziprasidone in Parkinsonian dopamine psychosis].
    Durán-Ferreras E; Alvarez-López M; García-Moreno JM; Chacón J
    Rev Neurol; 2008 Apr 16-30; 46(8):476-80. PubMed ID: 18428105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Benefit of L-DOPA-without-DCI (decarboxylase inhibitor) therapy on wearing-off phenomenon in advanced stages of Parkinson's disease patients].
    Hironishi M; Miwa H; Kondo T
    No To Shinkei; 2002 Feb; 54(2):127-32. PubMed ID: 11889758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-induced psychosis and depression in the elderly.
    Wood KA; Harris MJ; Morreale A; Rizos AL
    Psychiatr Clin North Am; 1988 Mar; 11(1):167-93. PubMed ID: 2898132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sexual side effects of treatment with psychopharmaceuticals].
    Kristensen E
    Ugeskr Laeger; 2002 Oct; 164(41):4753-6. PubMed ID: 12407874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poor visual discrimination and visual hallucinations in Parkinson's disease.
    Diederich NJ; Goetz CG; Raman R; Pappert EJ; Leurgans S; Piery V
    Clin Neuropharmacol; 1998; 21(5):289-95. PubMed ID: 9789709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of drug-induced psychosis in Parkinson's disease with clozapine.
    Greene P; Cote L; Fahn S
    Adv Neurol; 1993; 60():703-6. PubMed ID: 8420214
    [No Abstract]   [Full Text] [Related]  

  • 37. [Complications of drug withdrawal from antiparkinson agents and neuroleptics].
    Mizon JP; Rosa A
    Therapie; 1984; 39(4):421-5. PubMed ID: 6148792
    [No Abstract]   [Full Text] [Related]  

  • 38. [Strategies of psychopharmacotherapy in the elderly (author's transl)].
    Jellinger K
    Aktuelle Gerontol; 1980 Jul; 10(7):291-304. PubMed ID: 6107051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The psychiatric side-effects of drugs.
    Johnson DA
    Practitioner; 1972 Sep; 209(251):320-6. PubMed ID: 4404212
    [No Abstract]   [Full Text] [Related]  

  • 40. Development and progression of motor fluctuations and side effects in Parkinson's disease: comparison of Sinemet CR versus carbidopa/levodopa.
    Goetz CG; Tanner CM; Gilley DW; Klawans HL
    Neurology; 1989 Nov; 39(11 Suppl 2):63-6; discussion 72-3. PubMed ID: 2586764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.